SCHEMBL19001418

SCHEMBL19001418

C1#COCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5315441 0.77
SCHEMBL23904 0.67
SCHEMBL4454206 0.62
SCHEMBL50539 0.62
Fluoride SCHEMBL27979818 0.59
Fluoride SCHEMBL27829418 0.59
SCHEMBL1150 0.57
SCHEMBL379663 0.57
SCHEMBL1553484 0.57
SCHEMBL3185118 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3129360-B1 DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES BASF SE (DE) 2018-10-17 EP claimed
US-20220143020-A1 2-AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2022-05-12 US disclosed
WO-2017186700-A1 CRYSTALLINE FORMS OF N-[2-(3-HYDROXY-3-METHYLBUTYL)-6-(2-HYDROXYPROPAN-2-YL)-2H-INDAZOL-5-YL]-6-(TRIFLUOROMETHYL)PYRIDINE-2-CARBOXAMIDE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-11-02 WO disclosed
EP-2760285-B1 INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF SAMUMED LLC (US) 2017-06-21 EP disclosed